CClinicalTrials.gg
CompletedNCT03468569Updated Mar 16, 2018

Functional Movement Analysis of Handball Players

An interventional study of Functional Movement Screen in Injuries and Sports Physical Therapy, sponsored by Medipol University. Completed. Open to participants aged 16 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-16.

Sponsored by Medipol University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Non-randomized
Ages
16 Years to 35 Years
Sex
All
01

Study summary

RELATIONSHIP OF FUNCTIONAL MOVEMENT ANALYSIS WITH INJURY HISTORY AND ATHLETIC PARAMETERS IN HANDBALL ATHLETES

Abstract Objectives: Handball is a popular sport in many countries. There is lack of knowledge about handball athlete's functional movement capacity. The aim of this study is to investigate the Functional Movement Screen (FMS™) scores, to evaluate the injury risks of handball athletes and to determine its relationship with athletic performance.

Design: Observational study. Methods: A total of 51 professional handball players in Turkey were included in this study. The sport-specific features and demographic data were recorded. The functional movement analysis was performed and agility and balance and force were evaluated.

Read the detailed description

In august 2018, same evaluations will be done for same individuals.

02

Conditions studied

  • Injuries
  • Sports Physical Therapy

Browse trials for

Keywords

  • Athletic Performance
  • Functional Movement Screen
  • Handball Athletes
  • Injury Prevention
  • Injury History
03

Who can participate

Ages eligible
16 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Become a team licensed handball athlete between ages 16-35
  • Have not had a surgical operation involving the musculoskeletal system in the last six months
  • Not having an obstacle to the realization of the tests to be carried out in the study
  • Volunteering to participate in the work

Exclusion criteria

Exclusion Criteria:

  • If feeling any discomfort during the tests
  • Do not want to go on study
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Functional Movement Screen

    Movement Analysis for injury risk

    Other: Functional Movement Screen

  • Experimental
    Vertical Jump Test

    Jump test Height Measurement, Functional Movement Screen

    Other: Functional Movement Screen

  • Experimental
    Y Balance Test

    Functional lower extremity reach with balance, Functional Movement Screen

    Other: Functional Movement Screen

  • Experimental
    Illinois Agility Test

    Agility measurement, Functional Movement Screen

    Other: Functional Movement Screen

  • No intervention
    Injury History

    Athletes injury history for last year was recorded as injury count.

Interventions

  • OtherFunctional Movement Screen
05

What researchers measure

Primary outcomes

  1. Functional Movement Screen Assessment (FMS)

    0-21 (It has 7 subtests, and minimum 0 and maximum 3 is given for scoring.) Higher scores are better. For bilateral subtests, scoring is performed for both sides, and scoring is given according to lower side. ( Example; Right 2, Left 1 so 1 point score is given for that parameter. At last, all 7 scores summed for total score(0/21).

    Time frame: 20 minutes

Secondary outcomes

  1. Vertical Jump Test

    Inches, Higher scores are better.

    Time frame: 5 minutes

  2. Y Balance Test

    Functional Reach Measurement, higher scores are better.

    Time frame: 10 minutes

  3. Illinois Agility Test

    Agility Measurement, Lower scores are better.

    Time frame: 2 minutes

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Cook G, Burton L, Hoogenboom B. Pre-participation screening: the use of fundamental movements as an assessment of function - part 1. N Am J Sports Phys Ther. 2006 May;1(2):62-72. PubMed 21522216 ↗
  • Cook G, Burton L, Hoogenboom B. Pre-participation screening: the use of fundamental movements as an assessment of function - part 2. N Am J Sports Phys Ther. 2006 Aug;1(3):132-9. PubMed 21522225 ↗
  • Plisky PJ, Gorman PP, Butler RJ, Kiesel KB, Underwood FB, Elkins B. The reliability of an instrumented device for measuring components of the star excursion balance test. N Am J Sports Phys Ther. 2009 May;4(2):92-9. PubMed 21509114 ↗
  • Hachana Y, Chaabene H, Nabli MA, Attia A, Moualhi J, Farhat N, Elloumi M. Test-retest reliability, criterion-related validity, and minimal detectable change of the Illinois agility test in male team sport athletes. J Strength Cond Res. 2013 Oct;27(10):2752-9. doi: 10.1519/JSC.0b013e3182890ac3. PubMed 23439329 ↗
  • Raya MA, Gailey RS, Gaunaurd IA, Jayne DM, Campbell SM, Gagne E, Manrique PG, Muller DG, Tucker C. Comparison of three agility tests with male servicemembers: Edgren Side Step Test, T-Test, and Illinois Agility Test. J Rehabil Res Dev. 2013;50(7):951-60. doi: 10.1682/JRRD.2012.05.0096. PubMed 24301432 ↗
  • Carlock JM, Smith SL, Hartman MJ, Morris RT, Ciroslan DA, Pierce KC, Newton RU, Harman EA, Sands WA, Stone MH. The relationship between vertical jump power estimates and weightlifting ability: a field-test approach. J Strength Cond Res. 2004 Aug;18(3):534-9. doi: 10.1519/R-13213.1. PubMed 15320676 ↗
  • Atalay ES, Tarakci D, Algun C. Are the functional movement analysis scores of handball players related to athletic parameters? J Exerc Rehabil. 2018 Dec 27;14(6):954-959. doi: 10.12965/jer.1836372.186. eCollection 2018 Dec. PubMed 30656154 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03468569
Lead sponsor
Medipol University
Responsible party
Emre Serdar Vayvay (Lecturer, Medipol University) — Principal investigator
First posted
Mar 16, 2018
Start date
Aug 1, 2016
Primary completion
May 18, 2017
Completion
May 18, 2017
Last update
Mar 16, 2018

Study contacts

Devrim Tarakcı, PhD
principal investigator · Medipol University
Emre Serdar Vayvay, PhD
study director · Medipol University
Candan Algun, PhD,Prof
study chair · Medipol University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion